Logotype for Cembre S.p.A.

Cembre (CMB) Q1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Cembre S.p.A.

Q1 2025 earnings summary

23 Oct, 2025

Executive summary

  • Consolidated sales reached €60.0 million in Q1 2025, up 2.3% year-over-year, with net profit rising 22.4% to €11.9 million, representing 19.8% of sales.

  • EBITDA margin improved to 32.6% from 28.2% in Q1 2024, and EBIT margin rose to 26.9% from 22.7%.

  • Growth was driven by strong export performance, especially in the UK, Spain, and France, offsetting a 6.5% decline in Italian sales.

  • The Board approved a new share buy-back program and launched a five-year incentive plan for executives and managers.

  • Ongoing investments in production capacity and automation, with €29.5 million invested in 2024 and major expansion projects underway.

Financial highlights

  • Q1 2025 sales: €60.0 million (+2.3% YoY); EBITDA: €19.6 million (32.6% margin); EBIT: €16.1 million (26.9% margin); Net profit: €11.9 million (19.8% margin).

  • Net financial position improved to €7.1 million at March 31, 2025, from €2.0 million at December 31, 2024.

  • Export sales rose 9.8% year-over-year, while Italian sales declined 6.5%.

  • UK subsidiary sales up 18.6% YoY; Spain +14.5%; France +8.2%; Germany +5.7%; USA +0.2%.

  • Dividend yield averaged 4.4% over the last 5 years; 2024 dividend per share €1.88.

Outlook and guidance

  • Management expects consolidated turnover and economic results to grow in 2025, despite economic uncertainty and geopolitical tensions.

  • Cumulative sales for the first four months of 2025 grew 5.0% over the same period in 2024.

  • Focus on strengthening competitive advantage through new product development, R&D, and higher foreign market penetration, especially in the US and Germany.

  • Continued investment in automation and production capacity, including €42 million expansion for electrical connectors.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more